Bright Minds Biosciences Inc. (CSE: DRUG)

Bright Minds Biosciences Statistics

Total Valuation

Bright Minds Biosciences has a market cap or net worth of CAD 6.56 million. The enterprise value is 385,610.

Market Cap	6.56M
Enterprise Value	385,610

Important Dates

The next estimated earnings date is Friday, December 27, 2024.

Earnings Date	Dec 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Bright Minds Biosciences has 4.46 million shares outstanding. The number of shares has increased by 19.17% in one year.

Shares Outstanding	4.46M
Shares Change (YoY)	+19.17%
Shares Change (QoQ)	+4.15%
Owned by Insiders (%)	28.69%
Owned by Institutions (%)	4.43%
Float	3.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.08
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.11
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 35.08, with a Debt / Equity ratio of 0.23.

Current Ratio	35.08
Quick Ratio	34.75
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-536.87

Financial Efficiency

Return on equity (ROE) is -51.80% and return on invested capital (ROIC) is -30.53%.

Return on Equity (ROE)	-51.80%
Return on Assets (ROA)	-28.86%
Return on Capital (ROIC)	-30.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.45%
50-Day Moving Average	1.46
200-Day Moving Average	1.78
Relative Strength Index (RSI)	51.51
Average Volume (20 Days)	1,658

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.40M
Pretax Income	-3.58M
Net Income	-3.58M
EBITDA	n/a
EBIT	-3.40M
Earnings Per Share (EPS)	-0.87

Balance Sheet

The company has 6.19 million in cash and 14,016 in debt, giving a net cash position of 6.18 million or 1.38 per share.

Cash & Cash Equivalents	6.19M
Total Debt	14,016
Net Cash	6.18M
Net Cash Per Share	1.38
Equity (Book Value)	6.10M
Book Value Per Share	1.37
Working Capital	6.09M

Cash Flow

Operating Cash Flow	-2.58M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bright Minds Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.17%
Shareholder Yield	-19.17%
Earnings Yield	-58.91%
FCF Yield	n/a

Stock Splits

The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Jul 14, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a